Deking Medical Launches DKutting™ Scoring PTA Balloon and DKaptain™ High-Pressure Balloon in the U.S. Market
DK Medtech
Vascular Interventional Balloon Product Developer
DK Medtech
Recently,DK Medical Technology (Suzhou) Co., Ltd.With Two Star Products ——DKutting™ High-Pressure Scoring Balloon and DKaptain™ High-Pressure Balloon Launch in the U.S. Market, injecting new vitality into the global dialysis access and peripheral vascular disease treatment fields, and opening a new chapter in vascular interventional therapy!
Innovative Design, DKutting™ High-Pressure Scoring Balloon Leads the New Trend in Treatment
DKutting™ High-Pressure Scoring Balloon: The "Hexagonal Warrior" Showcases Excellence in the U.S. Market
Powerful Performance, DKaptain™ High-Pressure Balloon Breaks Through Treatment Challenges
DKaptain™ High-Pressure Balloon is also impressive. Specifically developed to address challenging issues such as vascular stenosis and occlusion, it utilizes high-quality balloon material, providing the balloon with excellent pressure resistance. In actual treatment, it can precisely and efficiently dilate narrowed blood vessels, ensuring smooth hemodialysis access. Moreover, the product materials have been rigorously selected and tested, exhibiting superior biocompatibility, which reduces the risk of post-treatment vascular irritation and inflammatory responses, safeguarding the long-term patency of patients' dialysis access.
Based in the United States, Looking Forward to a New Future of Global Medical Cooperation
The launch of DKutting™ High-Pressure Scoring Balloon and DKaptain™ High-Pressure Balloon in the United States further enhances DK Medtech's product portfolio in the global dialysis access and peripheral vascular disease treatment fields. This not only represents high recognition of the performance and quality of DK Medtech’s products but also marks an important milestone for the company in expanding into the global medical market and promoting international medical collaboration. As a leader in global medical technology, the U.S. boasts a vast and highly professional medical market. Starting here, DK Medtech will continue to deeply listen to clinical needs and constantly optimize its products and services. We look forward to collaborating with medical institutions and professionals across the U.S. and around the world, jointly exploring more possibilities in the field of interventional vascular therapy, bringing high-quality medical technologies to more patients, and contributing to the advancement of global healthcare.
Click "Read Original" at the bottom of the article to be redirected to the Mozarc company website for product details.
DK Medtech
Since its establishment in 2015, DK Medtech has consistently adhered to innovation as its driving force and has become a leading Chinese enterprise in the full range of interventional balloon innovations. It has developed more than ten types of balloons, including standard balloons, high-pressure balloons, scoring balloons, and drug-coated scoring balloons. Its product line covers the needs of almost all vascular intervention fields, including cardiovascular intervention, peripheral intervention, and neurointervention. Multiple products have received international certifications such as EU CE MDR and US FDA. The company's self-developed directional scoring technology is utilized in coronary scoring balloons, peripheral scoring balloons, and drug-coated scoring balloons. According to published pre-market RCT studies, its clinical performance shows significantly better clinical benefits compared to imported control groups, achieving excellent results and market position in niche markets.
